Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
The Holy Grail In Cancer? FDA Mulls New Blood Tests. ↗
Via Investor's Business Daily
Exposures Product Safety
News headline image
ELIS Manufacturing & Packaging Details Sports Nutrition Manufacturing Standards in GMP Certified Facility
Via Press Advantage
Exposures Product Safety
News headline image
Kaplan Fox Reminds Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Investors of an Ongoing Securities Law Investigation
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
Kaplan Fox Announces an Investigation of Medline Inc. (NASDAQ: MDLN) on Behalf of Investors
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Buy Phentermine Online: Eligibility, Clinical Review, and How Legal Access Works ↗
Via Talk Markets
Exposures Product Safety
News headline image
Lucid Approaches a Make-or-Break Period as Preparation for Turnaround Begins ↗
Via The Motley Fool
Topics Bankruptcy Electric Vehicles Product Recall
Tickers LCID RIVN
Exposures Electric Vehicles Financial Legal
News headline image
Ocular Therapeutix Eyes Q4 FDA Filing for AXPAXLI After SOL-1 Success ↗
Via MarketBeat
Tickers AMD OCUL
Exposures Product Safety
News headline image
Kaplan Fox Deadline Alert: Beta Bionics, Inc. (NASDAQ: BBNX) Investors Have Until November 3, 2026 to Seek a Lead Plaintiff Role
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
Quetiapine For Schizophrenia Treatment: Usage & Side Effects Guide Released
Via Press Release Distribution Service
Topics Derivatives
Exposures Derivatives Product Safety
News headline image
Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 2, 2026
Via NewMediaWire
Topics Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
News headline image
Compassion Behavioral Health Publishes New Resource on GLP-1 Research
Via Press Advantage
Exposures Product Safety
News headline image
Kaplan Fox Continues to Alert Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Class Action Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Compass Pathways Eyes 2027 COMP360 Launch as FDA Review Advances ↗
Via MarketBeat
Topics Cannabis Government
Tickers CMPS MS
Exposures Cannabis Political Product Safety
News headline image
Kaplan Fox Urges Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Deadline on November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Receives USPTO Notice of Allowance for LP-284 Blood Cancer Treatment Patent
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Tickers LTRN
Exposures Artificial Intelligence Intellectual Property Product Safety
News headline image
Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
PureTech Health H1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings Initial Public Offering
Tickers PRTC
Exposures Financial Product Safety Securities Market
News headline image
Compass Pathways Eyes 2027 COMP360 Launch as FDA Filing Nears ↗
Via MarketBeat
Topics Cannabis Government
Tickers CMPS DB
Exposures Cannabis Political Product Safety
News headline image
Liquid Rhinoplasty for Subtle Nose Enhancement ↗
Via Talk Markets
Exposures Product Safety
News headline image
Morpheus8 Radiofrequency for Skin and Scar Refinement ↗
Via Talk Markets
Exposures Product Safety
News headline image
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion ↗
Via MarketBeat
Topics Artificial Intelligence
Tickers MS TEM
Exposures Artificial Intelligence Product Safety
News headline image
Kaplan Fox Announces a Securities Class Action Filed Against Beta Bionics, Inc. (NASDAQ: BBNX) - Lead Plaintiff Deadline is November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
Non-Invasive Neuromodulation Support for Heart Rate Variability: Guide Published
Via Press Release Distribution Service
Exposures Product Safety
News headline image
BPC-157 & TB-500 Peptide Strips for Recovery Support: Wolverine Stack Launched
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth ↗
Via The Motley Fool
Topics Product Recall
Tickers ABT ISRG
Exposures Legal Product Safety
News headline image
How Much Caffeine Is Too Much for Your Daily Routine?
Via BusinesNews Wire
Exposures Product Safety
News headline image
Grail Catapults 30%-Plus As FDA Mulls Cancer-Detecting Blood Test ↗
Via Investor's Business Daily
Exposures Product Safety
News headline image
Kaplan Fox is Investigating Potential Securities Law Violations Against Medline Inc. (NASDAQ: MDLN)
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Kaplan Fox Urges Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Investors to Contact the Firm Regarding a Securities Investigation
Via NewMediaWire
Tickers FULC
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.